Market Overview

Analysts Come Out Bullish On Radius Health, Shares Rally

Related RDUS
Upcoming Corporate Events/Presentations for the Week of Aug. 11-15th
Benzinga's Top Initiations

Early Wednesday morning, four analyst firms issued notes initiating bullish coverage on Radius Health (NASDAQ: RDUS).

Shares of Radius Health have shot up nearly six percent on the news. The firms respective ratings and price targets are listed below.

  • Canaccord Genuity - Buy, $21
  • Cowen & Company - Outperform, N/A
  • Cantor Fitzgerald - Buy, $20
  • Jefferies - Buy, $17

The average of these price targets is $19.33, which represents 53 percent upside to last check price of $12.62.

Latest Ratings for RDUS

DateFirmActionFromTo
Jul 2014Canaccord GenuityInitiates Coverage onBuy
Jul 2014JefferiesInitiates Coverage onBuy
Jul 2014Cantor FitzgeraldInitiates Coverage onBuy

View More Analyst Ratings for RDUS
View the Latest Analyst Ratings

Posted-In: Canaccord Genuity Cantor FitzgeraldAnalyst Color Price Target Initiation Hot Analyst Ratings Movers

 

Related Articles (RDUS)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters